Health US FDA to Review Sarepta’s Duchenne Gene Therapy for Traditional Approval Posted on February 17, 2024 by miyuru (Reuters) – Sarepta Therapeutics said on Friday that the US FDA would review an application seeking traditional approval for its gene therapy to treat a muscle-wasting disorder by June 21,….
